U.S. markets closed
  • S&P 500

    3,768.25
    -27.29 (-0.72%)
     
  • Dow 30

    30,814.26
    -177.24 (-0.57%)
     
  • Nasdaq

    12,998.50
    -114.10 (-0.87%)
     
  • Russell 2000

    2,123.20
    -32.15 (-1.49%)
     
  • Crude Oil

    51.93
    -0.43 (-0.82%)
     
  • Gold

    1,826.80
    -3.10 (-0.17%)
     
  • Silver

    24.88
    +0.01 (+0.04%)
     
  • EUR/USD

    1.2073
    -0.0012 (-0.10%)
     
  • 10-Yr Bond

    1.0970
    -0.0320 (-2.83%)
     
  • GBP/USD

    1.3563
    -0.0021 (-0.15%)
     
  • USD/JPY

    103.7560
    -0.0440 (-0.04%)
     
  • BTC-USD

    35,065.88
    -665.71 (-1.86%)
     
  • CMC Crypto 200

    681.31
    -53.83 (-7.32%)
     
  • FTSE 100

    6,735.71
    -66.25 (-0.97%)
     
  • Nikkei 225

    28,236.26
    -282.92 (-0.99%)
     

UK asks regulator to assess Pfizer vaccine for suitability

·1 min read

LONDON, Nov 20 (Reuters) - Britain has formally asked its medical regulator, the MHRA, to assess the vaccine being produced by Pfizer Inc and its German partner BioNTech , health minister Matt Hancock said on Friday.

Pfizer said it would apply to U.S. health regulators on Friday for emergency use authorization (EUA) of its COVID-19 vaccine, the first such application in a major step toward providing protection against the new coronavirus.

"Here in the UK, the first step for authorising a vaccine is for the government formally to ask the independent regulator..., the MHRA, to assess its suitability," Hancock told reporters.

"I can confirm that the government has formally asked the MHRA to assess the Pfizer BioNTech vaccine for its suitability for authorisation."

(Reporting by Kate Holton and Elizabeth Piper; editing by Stephen Addison)